57/120
All 120 Win/Lose results shown below
Every strict quarterly win earns 1 point. A loss, tie, or unavailable scoring value earns 0. Gray context columns never affect the score. CEO quarterly pay is the explicitly marked annual ÷ 4 estimate.
Trailing 1 year (4 quarters): 2 wins, 10 lossesLast fetched: 4 Sept 2026
Complete point ledger
Each cell identifies the missing side explicitly. Unavailable evidence scores 0 only in Win/Lose columns; gray columns award no points.
| Quarter | Total return | Revenue growth | EPS growth | Net marginNon-scoring | Trailing P/ENon-scoring | Price/bookNon-scoring | CEO quarterly payNon-scoring | Implied DilutionNon-scoring | Implied BuybackNon-scoring |
|---|---|---|---|---|---|---|---|---|---|
| 2026-Q20/3 |
LoseIVF / S&P -30.15% / 15.20% |
LoseIVF / S&P 13.19% / 15.00% |
LoseIVF / S&P -106.19% / 50.40% |
Non-scoringIVF / S&P -82.33% / 15.70% | Non-scoringIVF / S&P IVF unavailable / 28.47 | Non-scoringIVF / S&P 0.26 / S&P unavailable | Non-scoringIVF / S&P IVF unavailable / S&P unavailable | Non-scoringIVF / S&P IVF unavailable / $0.00b | Non-scoringIVF / S&P IVF unavailable / $0.36b |
| 2026-Q10/3 |
LoseIVF / S&P -27.76% / -4.33% |
LoseIVF / S&P 8.95% / 11.30% |
LoseIVF / S&P -101.44% / 27.70% |
Non-scoringIVF / S&P -148.32% / 14.80% | Non-scoringIVF / S&P IVF unavailable / 25.43 | Non-scoringIVF / S&P 0.30 / S&P unavailable | Non-scoringIVF / S&P IVF unavailable / S&P unavailable | Non-scoringIVF / S&P IVF unavailable / $0.27b | Non-scoringIVF / S&P IVF unavailable / $0.00b |
| 2025-Q40/3 |
LoseIVF / S&P -87.62% / 2.65% |
LoseIVF / S&P 4.34% / 9.00% |
LoseIVF / S&P -10.68% / 13.40% |
Non-scoringIVF / S&P -329.72% / 13.20% | Non-scoringIVF / S&P IVF unavailable / 28.48 | Non-scoringIVF / S&P 0.25 / 5.39 | Non-scoringIVF / S&P IVF unavailable / $4.42m | Non-scoringIVF / S&P IVF unavailable / $0.00b | Non-scoringIVF / S&P IVF unavailable / $0.20b |
| 2025-Q32/3 |
LoseIVF / S&P -71.21% / 8.12% |
WinIVF / S&P 12.04% / 4.61% |
WinIVF / S&P 6990.47% / 13.45% |
Non-scoringIVF / S&P -393.47% / 11.78% | Non-scoringIVF / S&P IVF unavailable / 28.13 | Non-scoringIVF / S&P 28.34 / 5.27 | Non-scoringIVF / S&P IVF unavailable / $4.42m | Non-scoringIVF / S&P IVF unavailable / $0.11b | Non-scoringIVF / S&P IVF unavailable / $0.00b |
| 2025-Q22/3 |
LoseIVF / S&P -56.00% / 10.94% |
WinIVF / S&P 15.32% / 4.83% |
WinIVF / S&P 8113.59% / 10.63% |
Non-scoringIVF / S&P -397.38% / 11.45% | Non-scoringIVF / S&P IVF unavailable / 27.10 | Non-scoringIVF / S&P IVF unavailable / 5.01 | Non-scoringIVF / S&P IVF unavailable / $4.42m | Non-scoringIVF / S&P IVF unavailable / $0.00b | Non-scoringIVF / S&P IVF unavailable / $0.23b |
| 2025-Q12/3 |
LoseIVF / S&P -79.42% / -4.27% |
WinIVF / S&P 55.96% / 4.98% |
WinIVF / S&P 9822.11% / 10.57% |
Non-scoringIVF / S&P -378.28% / 11.39% | Non-scoringIVF / S&P IVF unavailable / 26.23 | Non-scoringIVF / S&P IVF unavailable / 4.69 | Non-scoringIVF / S&P IVF unavailable / $4.42m | Non-scoringIVF / S&P IVF unavailable / $0.00b | Non-scoringIVF / S&P IVF unavailable / $0.10b |
| 2024-Q43/3 |
WinIVF / S&P 14.08% / 2.41% |
WinIVF / S&P 117.21% / 5.25% |
WinIVF / S&P 5325.10% / 6.15% |
Non-scoringIVF / S&P -141.12% / 11.29% | Non-scoringIVF / S&P IVF unavailable / 28.60 | Non-scoringIVF / S&P 0.29 / 4.99 | Non-scoringIVF / S&P IVF unavailable / $4.28m | Non-scoringIVF / S&P IVF unavailable / $0.00b | Non-scoringIVF / S&P IVF unavailable / $0.08b |
| 2024-Q32/3 |
LoseIVF / S&P -15.48% / 5.89% |
WinIVF / S&P 224.88% / 5.89% |
WinIVF / S&P 759.47% / 6.11% |
Non-scoringIVF / S&P -119.90% / 10.87% | Non-scoringIVF / S&P IVF unavailable / 28.09 | Non-scoringIVF / S&P IVF unavailable / 4.94 | Non-scoringIVF / S&P IVF unavailable / $4.28m | Non-scoringIVF / S&P IVF unavailable / $0.00b | Non-scoringIVF / S&P IVF unavailable / $0.21b |
| 2024-Q22/3 |
LoseIVF / S&P -25.66% / 4.28% |
WinIVF / S&P 390.03% / 5.38% |
WinIVF / S&P 480.19% / 5.12% |
Non-scoringIVF / S&P -122.80% / 10.85% | Non-scoringIVF / S&P IVF unavailable / 27.64 | Non-scoringIVF / S&P 3427.89 / 4.79 | Non-scoringIVF / S&P IVF unavailable / $4.28m | Non-scoringIVF / S&P IVF unavailable / $0.00b | Non-scoringIVF / S&P IVF unavailable / $0.36b |
| 2024-Q12/3 |
LoseIVF / S&P -16.30% / 10.56% |
WinIVF / S&P 321.67% / 5.71% |
WinIVF / S&P 317.64% / 5.59% |
Non-scoringIVF / S&P -166.64% / 10.81% | Non-scoringIVF / S&P IVF unavailable / 27.02 | Non-scoringIVF / S&P 419503.68 / 4.71 | Non-scoringIVF / S&P IVF unavailable / $4.28m | Non-scoringIVF / S&P IVF unavailable / $0.00b | Non-scoringIVF / S&P IVF unavailable / $0.12b |
| 2023-Q43/3 |
WinIVF / S&P 70.89% / 11.69% |
WinIVF / S&P 267.38% / 6.81% |
WinIVF / S&P 411.18% / 7.78% |
Non-scoringIVF / S&P -266.00% / 11.19% | Non-scoringIVF / S&P IVF unavailable / 24.35 | Non-scoringIVF / S&P 452.26 / 4.31 | Non-scoringIVF / S&P IVF unavailable / $4.08m | Non-scoringIVF / S&P IVF unavailable / $0.00b | Non-scoringIVF / S&P IVF unavailable / $0.01b |
| 2023-Q31/3 |
LoseIVF / S&P -80.25% / -3.27% |
LoseIVF / S&P -46.64% / 7.52% |
WinIVF / S&P 37.74% / -5.03% |
Non-scoringIVF / S&P -459.42% / 10.84% | Non-scoringIVF / S&P IVF unavailable / 23.93 | Non-scoringIVF / S&P 7551.74 / 3.98 | Non-scoringIVF / S&P IVF unavailable / $4.08m | Non-scoringIVF / S&P IVF unavailable / $0.00b | Non-scoringIVF / S&P IVF unavailable / $0.24b |
| 2023-Q21/3 |
LoseIVF / S&P -68.70% / 8.74% |
LoseIVF / S&P -67.07% / 9.50% |
WinIVF / S&P 214.23% / -8.57% |
Non-scoringIVF / S&P -858.51% / 10.88% | Non-scoringIVF / S&P IVF unavailable / 24.01 | Non-scoringIVF / S&P IVF unavailable / 4.19 | Non-scoringIVF / S&P IVF unavailable / $4.08m | Non-scoringIVF / S&P IVF unavailable / $0.00b | Non-scoringIVF / S&P IVF unavailable / $0.17b |
| 2023-Q12/3 |
WinIVF / S&P 50.71% / 7.50% |
LoseIVF / S&P -72.30% / 10.77% |
WinIVF / S&P 2762.30% / -15.69% |
Non-scoringIVF / S&P -1058.84% / 10.82% | Non-scoringIVF / S&P IVF unavailable / 22.66 | Non-scoringIVF / S&P 2906385.55 / 3.93 | Non-scoringIVF / S&P IVF unavailable / $4.08m | Non-scoringIVF / S&P IVF unavailable / $0.00b | Non-scoringIVF / S&P IVF unavailable / $0.13b |
| 2022-Q41/3 |
LoseIVF / S&P -60.00% / 7.56% |
LoseIVF / S&P -80.24% / 11.88% |
WinIVF / S&P 2057.14% / -17.99% |
Non-scoringIVF / S&P -1324.81% / 11.09% | Non-scoringIVF / S&P IVF unavailable / 22.65 | Non-scoringIVF / S&P IVF unavailable / 3.75 | Non-scoringIVF / S&P IVF unavailable / $3.70m | Non-scoringIVF / S&P IVF unavailable / $0.00b | Non-scoringIVF / S&P IVF unavailable / $0.15b |
| 2022-Q33/3 |
WinIVF / S&P 65.63% / -4.88% |
WinIVF / S&P 174.55% / 13.47% |
WinIVF / S&P 615.08% / -1.41% |
Non-scoringIVF / S&P -230.13% / 12.28% | Non-scoringIVF / S&P IVF unavailable / 20.58 | Non-scoringIVF / S&P 288529.85 / 3.60 | Non-scoringIVF / S&P IVF unavailable / $3.70m | Non-scoringIVF / S&P IVF unavailable / $0.00b | Non-scoringIVF / S&P IVF unavailable / $0.17b |
| 2022-Q22/3 |
LoseIVF / S&P -75.76% / -16.10% |
WinIVF / S&P 150.82% / 13.71% |
WinIVF / S&P 266.67% / 11.04% |
Non-scoringIVF / S&P -222.61% / 13.03% | Non-scoringIVF / S&P IVF unavailable / 20.28 | Non-scoringIVF / S&P 66614.23 / 3.78 | Non-scoringIVF / S&P IVF unavailable / $3.70m | Non-scoringIVF / S&P IVF unavailable / $0.00b | Non-scoringIVF / S&P IVF unavailable / $0.17b |
| 2022-Q11/3 |
LoseIVF / S&P -20.72% / -4.60% |
WinIVF / S&P 148.64% / 15.97% |
LoseIVF / S&P -58.78% / 42.23% |
Non-scoringIVF / S&P -191.74% / 14.22% | Non-scoringIVF / S&P IVF unavailable / 22.19 | Non-scoringIVF / S&P 164531.76 / 4.51 | Non-scoringIVF / S&P IVF unavailable / $3.70m | Non-scoringIVF / S&P IVF unavailable / $0.00b | Non-scoringIVF / S&P IVF unavailable / $0.20b |
| 2021-Q41/3 |
LoseIVF / S&P 2.15% / 11.03% |
WinIVF / S&P 301.06% / 15.00% |
LoseIVF / S&P -58.55% / 96.40% |
Non-scoringIVF / S&P -159.97% / 15.13% | Non-scoringIVF / S&P IVF unavailable / 23.63 | Non-scoringIVF / S&P 156490.63 / 4.73 | Non-scoringIVF / S&P IVF unavailable / $3.63m | Non-scoringIVF / S&P IVF unavailable / $0.00b | Non-scoringIVF / S&P IVF unavailable / $0.13b |
| 2021-Q31/3 |
LoseIVF / S&P -29.89% / 0.58% |
WinIVF / S&P 11.90% / 10.77% |
LoseIVF / S&P 16.67% / 69.42% |
Non-scoringIVF / S&P -788.85% / 14.13% | Non-scoringIVF / S&P IVF unavailable / 25.35 | Non-scoringIVF / S&P 416976.07 / 4.38 | Non-scoringIVF / S&P IVF unavailable / $3.63m | Non-scoringIVF / S&P IVF unavailable / $0.00b | Non-scoringIVF / S&P IVF unavailable / $0.19b |
| 2021-Q22/3 |
LoseIVF / S&P 7.39% / 8.55% |
WinIVF / S&P 25.41% / 6.58% |
WinIVF / S&P 58.62% / 51.81% |
Non-scoringIVF / S&P -690.97% / 13.34% | Non-scoringIVF / S&P IVF unavailable / 26.70 | Non-scoringIVF / S&P 321377.64 / 4.43 | Non-scoringIVF / S&P IVF unavailable / $3.63m | Non-scoringIVF / S&P IVF unavailable / $0.00b | Non-scoringIVF / S&P IVF unavailable / $0.11b |
| 2021-Q12/3 |
WinIVF / S&P 43.85% / 6.17% |
LoseIVF / S&P -5.56% / -1.06% |
WinIVF / S&P 134.92% / 7.39% |
Non-scoringIVF / S&P -639.43% / 11.60% | Non-scoringIVF / S&P IVF unavailable / 30.50 | Non-scoringIVF / S&P 232195.26 / 4.23 | Non-scoringIVF / S&P IVF unavailable / $3.63m | Non-scoringIVF / S&P IVF unavailable / $0.00b | Non-scoringIVF / S&P IVF unavailable / $0.10b |
| 2020-Q41/3 |
LoseIVF / S&P IVF unavailable / 12.15% |
LoseIVF / S&P -29.92% / -3.72% |
WinIVF / S&P 347.06% / -33.42% |
Non-scoringIVF / S&P -804.73% / 8.86% | Non-scoringIVF / S&P IVF unavailable / 39.26 | Non-scoringIVF / S&P 145497.73 / 4.05 | Non-scoringIVF / S&P IVF unavailable / $3.17m | Non-scoringIVF / S&P IVF unavailable / $0.00b | Non-scoringIVF / S&P IVF unavailable / $0.01b |
| 2020-Q32/3 |
LoseIVF / S&P IVF unavailable / 8.93% |
WinIVF / S&P 33.90% / -2.04% |
WinIVF / S&P 500.00% / -27.10% |
Non-scoringIVF / S&P -452.94% / 9.24% | Non-scoringIVF / S&P IVF unavailable / 34.27 | Non-scoringIVF / S&P IVF unavailable / 3.65 | Non-scoringIVF / S&P IVF unavailable / $3.17m | Non-scoringIVF / S&P IVF unavailable / $0.02b | Non-scoringIVF / S&P IVF unavailable / $0.00b |
| 2020-Q22/3 |
LoseIVF / S&P IVF unavailable / 20.54% |
WinIVF / S&P 63.63% / -0.46% |
WinIVF / S&P 2800.00% / -27.11% |
Non-scoringIVF / S&P -372.51% / 9.37% | Non-scoringIVF / S&P IVF unavailable / 31.29 | Non-scoringIVF / S&P IVF unavailable / 3.44 | Non-scoringIVF / S&P IVF unavailable / $3.17m | Non-scoringIVF / S&P IVF unavailable / $0.00b | Non-scoringIVF / S&P IVF unavailable / $0.03b |
| 2020-Q12/3 |
LoseIVF / S&P IVF unavailable / -19.60% |
WinIVF / S&P 959.08% / 3.47% |
WinIVF / S&P 6200.00% / -14.75% |
Non-scoringIVF / S&P -203.53% / 10.68% | Non-scoringIVF / S&P IVF unavailable / 22.80 | Non-scoringIVF / S&P IVF unavailable / 2.92 | Non-scoringIVF / S&P IVF unavailable / $3.17m | Non-scoringIVF / S&P IVF unavailable / $0.00b | Non-scoringIVF / S&P IVF unavailable / $0.05b |
| 2019-Q42/3 |
LoseIVF / S&P IVF unavailable / 9.07% |
WinIVF / S&P 2326.58% / 5.36% |
WinIVF / S&P 3300.00% / 2.99% |
Non-scoringIVF / S&P -146.43% / 12.81% | Non-scoringIVF / S&P IVF unavailable / 22.78 | Non-scoringIVF / S&P IVF unavailable / 3.53 | Non-scoringIVF / S&P IVF unavailable / $3.08m | Non-scoringIVF / S&P IVF unavailable / $0.00b | Non-scoringIVF / S&P IVF unavailable / $0.05b |
| 2019-Q32/3 |
LoseIVF / S&P IVF unavailable / 1.70% |
WinIVF / S&P 107.55% / 5.02% |
WinIVF / S&P 1700.00% / 0.21% |
Non-scoringIVF / S&P -249.85% / 12.41% | Non-scoringIVF / S&P IVF unavailable / 22.44 | Non-scoringIVF / S&P IVF unavailable / 3.30 | Non-scoringIVF / S&P IVF unavailable / $3.08m | Non-scoringIVF / S&P IVF unavailable / $0.00b | Non-scoringIVF / S&P IVF unavailable / $0.09b |
| 2019-Q22/3 |
LoseIVF / S&P IVF unavailable / 4.30% |
WinIVF / S&P 90.90% / 6.64% |
WinIVF / S&P 200.00% / 8.65% |
Non-scoringIVF / S&P -254.26% / 12.79% | Non-scoringIVF / S&P IVF unavailable / 21.37 | Non-scoringIVF / S&P IVF unavailable / 3.32 | Non-scoringIVF / S&P IVF unavailable / $3.08m | Non-scoringIVF / S&P IVF unavailable / $0.00b | Non-scoringIVF / S&P IVF unavailable / $0.27b |
| 2019-Q10/3 |
LoseIVF / S&P IVF unavailable / 13.65% |
LoseIVF / S&P -56.21% / 8.12% |
LoseIVF / S&P IVF unavailable / 14.29% |
Non-scoringIVF / S&P -2317.24% / 12.97% | Non-scoringIVF / S&P IVF unavailable / 20.86 | Non-scoringIVF / S&P IVF unavailable / 3.26 | Non-scoringIVF / S&P IVF unavailable / $3.08m | Non-scoringIVF / S&P IVF unavailable / $0.00b | Non-scoringIVF / S&P IVF unavailable / $34.35b |
| 2018-Q40/3 |
LoseIVF / S&P IVF unavailable / -13.52% |
LoseIVF / S&P -78.38% / 9.05% |
LoseIVF / S&P IVF unavailable / 18.23% |
Non-scoringIVF / S&P -5042.77% / 13.10% | Non-scoringIVF / S&P IVF unavailable / 19.39 | Non-scoringIVF / S&P IVF unavailable / 2.94 | Non-scoringIVF / S&P IVF unavailable / $3.00m | Non-scoringIVF / S&P IVF unavailable / $0.01b | Non-scoringIVF / S&P IVF unavailable / $0.00b |
| 2018-Q31/3 |
LoseIVF / S&P IVF unavailable / 7.71% |
WinIVF / S&P 100.06% / 10.21% |
LoseIVF / S&P 0.00% / 19.06% |
Non-scoringIVF / S&P -595.66% / 13.01% | Non-scoringIVF / S&P IVF unavailable / 22.25 | Non-scoringIVF / S&P IVF unavailable / 3.45 | Non-scoringIVF / S&P IVF unavailable / $3.00m | Non-scoringIVF / S&P IVF unavailable / $0.00b | Non-scoringIVF / S&P IVF unavailable / $0.17b |
| 2018-Q21/3 |
LoseIVF / S&P IVF unavailable / 3.43% |
WinIVF / S&P 127.57% / 9.03% |
LoseIVF / S&P 0.00% / 14.46% |
Non-scoringIVF / S&P -648.53% / 12.56% | Non-scoringIVF / S&P IVF unavailable / 22.49 | Non-scoringIVF / S&P IVF unavailable / 3.25 | Non-scoringIVF / S&P IVF unavailable / $3.00m | Non-scoringIVF / S&P IVF unavailable / $0.00b | Non-scoringIVF / S&P IVF unavailable / $0.19b |
| 2018-Q11/3 |
LoseIVF / S&P IVF unavailable / -0.76% |
WinIVF / S&P 292.84% / 7.68% |
LoseIVF / S&P -100.00% / 12.46% |
Non-scoringIVF / S&P -189.20% / 12.27% | Non-scoringIVF / S&P IVF unavailable / 23.41 | Non-scoringIVF / S&P IVF unavailable / 3.17 | Non-scoringIVF / S&P IVF unavailable / $3.00m | Non-scoringIVF / S&P IVF unavailable / $0.00b | Non-scoringIVF / S&P IVF unavailable / $0.08b |
| 2017-Q41/3 |
LoseIVF / S&P IVF unavailable / 6.64% |
WinIVF / S&P 454.30% / 7.03% |
LoseIVF / S&P -100.00% / 13.82% |
Non-scoringIVF / S&P -248.87% / 12.09% | Non-scoringIVF / S&P IVF unavailable / 24.25 | Non-scoringIVF / S&P IVF unavailable / 3.23 | Non-scoringIVF / S&P IVF unavailable / $2.92m | Non-scoringIVF / S&P IVF unavailable / $0.00b | Non-scoringIVF / S&P IVF unavailable / $0.05b |
| 2017-Q31/3 |
LoseIVF / S&P IVF unavailable / 4.48% |
WinIVF / S&P 408.18% / 5.68% |
LoseIVF / S&P 0.00% / 17.57% |
Non-scoringIVF / S&P -369.51% / 12.04% | Non-scoringIVF / S&P IVF unavailable / 23.28 | Non-scoringIVF / S&P IVF unavailable / 3.08 | Non-scoringIVF / S&P IVF unavailable / $2.92m | Non-scoringIVF / S&P IVF unavailable / $0.00b | Non-scoringIVF / S&P IVF unavailable / $0.11b |
| 2017-Q21/3 |
LoseIVF / S&P IVF unavailable / 3.09% |
WinIVF / S&P 513.51% / 4.83% |
LoseIVF / S&P 0.00% / 17.74% |
Non-scoringIVF / S&P -524.69% / 11.96% | Non-scoringIVF / S&P IVF unavailable / 23.40 | Non-scoringIVF / S&P IVF unavailable / 3.03 | Non-scoringIVF / S&P IVF unavailable / $2.92m | Non-scoringIVF / S&P IVF unavailable / $0.00b | Non-scoringIVF / S&P IVF unavailable / $0.08b |
| 2017-Q11/3 |
LoseIVF / S&P IVF unavailable / 6.07% |
WinIVF / S&P 224.92% / 3.67% |
LoseIVF / S&P -50.00% / 13.32% |
Non-scoringIVF / S&P -2537.59% / 11.75% | Non-scoringIVF / S&P IVF unavailable / 23.60 | Non-scoringIVF / S&P IVF unavailable / 3.01 | Non-scoringIVF / S&P IVF unavailable / $2.92m | Non-scoringIVF / S&P IVF unavailable / $0.00b | Non-scoringIVF / S&P IVF unavailable / $20.24b |
| 2016-Q41/3 |
LoseIVF / S&P IVF unavailable / 3.82% |
WinIVF / S&P 335.46% / 2.09% |
LoseIVF / S&P -50.00% / 7.05% |
Non-scoringIVF / S&P -4173.30% / 11.37% | Non-scoringIVF / S&P IVF unavailable / 23.76 | Non-scoringIVF / S&P IVF unavailable / 2.91 | Non-scoringIVF / S&P IVF unavailable / $2.88m | Non-scoringIVF / S&P IVF unavailable / $0.00b | Non-scoringIVF / S&P IVF unavailable / $1.11b |
| 2016-Q31/3 |
LoseIVF / S&P IVF unavailable / 3.85% |
WinIVF / S&P 254.04% / 0.20% |
LoseIVF / S&P -83.33% / -3.15% |
Non-scoringIVF / S&P -5055.02% / 10.82% | Non-scoringIVF / S&P IVF unavailable / 24.22 | Non-scoringIVF / S&P IVF unavailable / 2.78 | Non-scoringIVF / S&P IVF unavailable / $2.88m | Non-scoringIVF / S&P IVF unavailable / $0.00b | Non-scoringIVF / S&P IVF unavailable / $0.16b |
Dividend-reinvested, split-adjusted total return
1Y · 2025-08-29 to 2026-08-27
| Metric | IVF total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | -97.32% | 20.78% |
| Annualized return | -97.32% | 20.78% |
5Y · 2021-09-01 to 2026-08-27
| Metric | IVF total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | -100.00% | 83.14% |
| Annualized return | -90.18% | 12.86% |
10Y · 2020-11-02 to 2026-08-27
| Metric | IVF total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | -100.00% | 319.30% |
| Annualized return | -72.60% | 15.41% |
Calculation rules
- window
- Latest 40 completed benchmark quarters; unavailable issuer evidence remains visible and scores 0.
- return Basis
- Issuer adjusted close reinvests distributions and normalizes splits; the S&P 500 Total Return Index is the direct benchmark.
- point Rule
- Strict same-quarter win = 1. Loss, tie or unavailable evidence = 0. No partial or subjective points.
- frequency
- Quarter endpoints only.
- fundamentals
- Trailing-four-quarter issuer revenue and EPS growth use the issuer's normalized government-filed facts.
- non Scoring
- Net margin, P/E, P/B and other gray context columns never enter the score.
Snapshot captured 2026-09-04.